About Savanna Biotherapeutics
Savanna Biotherapeutics is a private company based in Aliso Viejo, California, incorporated in 2020 in Delaware. It has reported $37,304,477 raised in two offerings on Form D since November 2022. Its chief executive is Robert Spitale.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2025 | Jun 30, 2025 | $12,999,997of $59.9M target | 30 | $433K | EquityRule 506(b) | Form D ↗ |
| Nov 3, 2022 | Nov 18, 2022 | $24,304,480of $54.3M target | 54 | $450K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $37,304,477 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Savanna Biotherapeutics's Form D filed Jun 30, 2025.
JB
Jeffrey Bird
Director
RS
Robert Spitale
Chief Executive Officer and director
KL
Keith Loebner
Director
KK
Kim Kamdar
Director
Earlier filings also listed Michael Speiser (director, last listed Nov 2022).